Accolade, Inc. (ACCD)

Market Cap	562.12M
Revenue (ttm)	446.72M
Net Income (ttm)	-180.30M
Shares Out	81.59M
EPS (ttm)	-2.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,414,625
Open	6.86
Previous Close	6.86
Day's Range	6.85 - 6.90
52-Week Range	3.08 - 13.93
Beta	2.08
Analysts	Buy
Price Target	6.36 (-7.69%)
Earnings Date	Jan 10, 2025

About ACCD

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management speci...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 2, 2020
• Employees: 2,400
• Stock Exchange: NASDAQ
• Ticker Symbol: ACCD
• Website: https://www.accolade.com

Financial Performance

In 2023, Accolade's revenue was $414.29 million, an increase of 14.09% compared to the previous year's $363.14 million. Losses were -$99.81 million, -78.29% less than in 2022.

Analyst Forecast

According to 11 analysts, the average rating for ACCD stock is "Buy." The 12-month stock price forecast is $6.36, which is a decrease of -7.69% from the latest price.

Price Target

$6.36

(-7.69% downside)

Analyst Consensus: Buy